Atlanta Cancer Care
Alpharetta, Georgia, United States
Cancer treatment center in Alpharetta, Georgia
3400 Old Milton Pkwy Suite 400, Alpharetta, GA 30005
About Atlanta Cancer Care
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Atlanta Cancer Care
During the past decade, Atlanta Cancer Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
2017-08-03
2024-08-01
Recruiting
650
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
2019-08-23
2027-11-22
Recruiting
683
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Cancer Care"
#1 collaborator was "BioNTech SE" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Atlanta Cancer Care
According to Clinical.Site data, the most researched conditions in "Atlanta Cancer Care" are
"Advanced Melanoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Atlanta Cancer Care" in a lesser frequency.
Clinical Trials Intervention Types at Atlanta Cancer Care
Most popular intervention types in "Atlanta Cancer Care" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (1 trials), "RO7198457" (1 trials), "Reparixin" (1 trials), "paclitaxel" (1 trials) and "placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Atlanta Cancer Care
The vast majority of trials in "Atlanta Cancer Care" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Atlanta Cancer Care
Currently, there are NaN active trials in "Atlanta Cancer Care".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Atlanta Cancer Care,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Atlanta Cancer Care, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".